Baylor Genetics
Mathilde Leary, MBA/MPH, is an experienced executive with a strong background in healthcare innovation and business development. Currently serving as Executive for Emerging Business, Strategic Partnerships, and Business Development at Baylor Genetics, Leary leads initiatives related to new products and strategic partnerships within genetics laboratory testing and precision medicine. Previous roles include Vice President/Chief Operating Officer at Memorial Hermann Health System, Managing Director at Health-e-Port, and Director positions at The Claro Group and KPMG, where Leary focused on enhancing healthcare delivery through strategic partnerships and operational improvements. Leary's education includes an MBA and MPH from Tulane University, complemented by a BA in Economics, Biology, and Pre-Medicine from Wake Forest University.
This person is not in any teams
Baylor Genetics
Baylor Genetics is a joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states and 16 countries.